BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 33791379)

  • 1. Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review.
    Marasine NR; Sankhi S; Lamichhane R; Marasini NR; Dangi NB
    Biomed Res Int; 2021; 2021():6699028. PubMed ID: 33791379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database.
    Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
    BMC Med; 2018 Mar; 16(1):36. PubMed ID: 29514662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database.
    Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
    BMJ; 2016 Mar; 352():i1350. PubMed ID: 27005565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.
    Caballero J; Nahata MC
    Ann Pharmacother; 2005 Jan; 39(1):141-5. PubMed ID: 15562140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline versus other antidepressive agents for depression.
    Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006117. PubMed ID: 20091586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline versus other antidepressive agents for depression.
    Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.
    De Vries C; Gadzhanova S; Sykes MJ; Ward M; Roughead E
    Drug Saf; 2021 Mar; 44(3):291-312. PubMed ID: 33354752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
    Kaplan C; Zhang Y
    J Ment Health Policy Econ; 2012 Dec; 15(4):171-8. PubMed ID: 23525835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients.
    Montgomery SA
    Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S49-54. PubMed ID: 9817621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
    Schlienger RG; Fischer LM; Jick H; Meier CR
    Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.